nei THIS MONTH IN
PSYCHOPHARMACOLOGY
Browsing articles in "Cognitive Disorders"

 

Pointing a Finger at Parkinson's Disease Dementia
January 12, 2018   

As many as 80% of patients with Parkinson's disease develop dementia (PDD)—a dementia that can be somewhat difficult to distinguish from Alzheimer's disease (AD). Appropriate diagnosis is key to planning as well as future application of disease-modifying treatments...
 Continue reading (Members only)
Ex-NFL Player Confirmed as First Case of Chronic Traumatic Encephalopathy in Living Patient
November 17, 2017   

New research appears to confirm that positron emission tomography (PET) imaging tracer can identify the distinctive brain tau pathology of chronic traumatic encephalopathy (CTE) in a living person....
 Continue reading (Members only)
Cognitive Remediation Can Improve Cognitive Function in Bipolar Disorder
November 3, 2017   

Cognitive remediation produced significant improvements over an active control in several cognitive domains...
 Continue reading
Combination Therapy Most Effective For Severe Pediatric Anxiety
October 23, 2017   

A recent secondary analysis of the Child/Adolescent Anxiety Multimodal Study (CAMS) was conducted to investigate predictors and moderators of pediatric anxiety...
 Continue reading (Members only)
Greater Cortical Thickness in Elderly Female Yoga Practitioners
July 22, 2017   

Yoga, mind-body activity has been associated with positive changes in brain structure and function, especially in areas related to attention, executive functions, and memory. Normal aging corresponds with structural and functional brain changes, that involve decreased cognitive function. In a recent cross-sectional study...
 Continue reading (Members only)
A Cross-Sectional Comparison of Brain Glucose and Ketone Metabolism in Cognitively Healthy Older Adults, Mild Cognitive Impairment (MCI) and Early Alzheimer’s Disease (AD)
July 19, 2017   

Deteriorating brain glucose metabolism precedes the clinical onset of AD and contributes to its etiology. Ketone bodies, mainly ß-hydroxybutyrate and acetoacetate are the primary alternative fuel to glucose. In a recent study...
 Continue reading (Members only)
Predicting the Risk of Mild Cognitive Impairment- Mayo Clinic Study of Aging
July 16, 2017   

A recent longitudinal study conducted by the Mayo Clinic examined approximately 1500 participants to develop risk scores for the progression from cognitively normal (CN) to mild cognitive impairment (MCI)...
 Continue reading (Members only)
Physical Exercise and Cognitive Function in Older Adults: Meta-Analysis
May 1, 2017   

A new meta-analysis has shown that physical exercise improves cognitive functioning in healthy adults over the age of 50...
 Continue reading (Members only)
Collaborative Care for Persistent Postconcussive Symptoms in Adolescents
December 8, 2016   

Sports-related concussions are often associated with postconcussive psychological symptoms, yet there is no evidence-based treatment for postconcussive symptoms in children and adolescents. A recent study tested a collaborative care intervention model...
 Continue reading (Members only)
CerefolinNAC Therapy of Hyperhomocysteinemia Delays Cortical and White Matter Atrophy in Alzheimer’s Disease and Cerebrovascular Disease
December 3, 2016   

In a recent study, patients with Alzheimer’s disease (AD) or cognitive impairment due to cerebrovascular disease (CVD) were treated with a medical food therapy for hyperhomocysteinemia (HHcy)...
 Continue reading (Members only)
12
Top of Page